We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

129 hedge funds and large institutions have $949M invested in Celldex Therapeutics in 2013 Q2 according to their latest regulatory filings, with 129 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less call options, than puts

Call options by funds: $7.11M | Put options by funds: $8.22M

Holders
129
Holders Change
+129
Holders Change %
–
% of All Funds
4.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
129
Increased
–
Reduced
–
Closed
–
Calls
$7.11M
Puts
$8.22M
Net Calls
-$1.11M
Net Calls Change
-$1.11M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
26
Ardsley Advisory Partners
Connecticut
$6.4M +$5.38M +27,333 New
RA
27
Royce & Associates
New York
$6.24M +$5.25M +26,667 New
TCIM
28
TIAA CREF Investment Management
New York
$6.05M +$5.09M +25,839 New
SCM
29
Sigma Capital Management
Connecticut
$6.01M +$5.05M +25,667 New
BG
30
BlackRock Group
United Kingdom
$5.71M +$4.8M +24,370 New
OAM
31
Oxford Asset Management
United Kingdom
$5.35M +$4.5M +22,849 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.27M +$4.43M +22,498 New
JP Morgan Chase
33
JP Morgan Chase
New York
$5.22M +$4.39M +22,316 New
Deutsche Bank
34
Deutsche Bank
Germany
$4.57M +$3.84M +19,510 New
TG
35
TCW Group
California
$4.54M +$3.81M +19,373 New
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$4.29M +$3.61M +18,333 New
WSA
37
Wall Street Associates
California
$3.96M +$3.33M +16,901 New
Millennium Management
38
Millennium Management
New York
$3.67M +$3.09M +15,684 New
RFC
39
Russell Frank Company
Washington
$3.58M +$3.01M +15,279 New
EI
40
EAM Investors
California
$3.45M +$2.9M +14,741 New
BIM
41
BlackRock Investment Management
Delaware
$3.42M +$2.87M +14,595 New
EMFAT
42
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.4M +$2.86M +14,519 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$3.35M +$2.82M +14,316 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.19M +$2.68M +13,608 New
Charles Schwab
45
Charles Schwab
California
$3.12M +$2.5M +12,708 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$3.05M +$2.56M +13,024 New
GC
47
Guggenheim Capital
Illinois
$3.01M +$2.53M +12,848 New
Prudential Financial
48
Prudential Financial
New Jersey
$2.88M +$2.42M +12,312 New
U
49
UBS
Switzerland
$2.21M +$1.86M +9,444 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$2.2M +$1.85M +9,395 New
1
2
3 4 5

CLDX Hedge Fund Activity: Q2 2013 in Review

129 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q2 2013, worth a combined $949M.

Buyers outnumbered sellers: 129 funds opened new CLDX positions and 0 closed out — a net gain of 129 holders — while 0 added to existing stakes and 0 trimmed.

  • 129 institutional investors held Celldex Therapeutics (CLDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $949M of Celldex Therapeutics stock for Q2 2013.
  • 129 funds opened new Celldex Therapeutics positions in Q2 2013 and 0 closed out, a net change of +129 holders.

Based on aggregated 13F filings for Q2 2013.